Redaporfin

(Synonyms: LUZ11; F2BMet)
目录号: PL10900 纯度: ≥98.0%
Redaporfin (LUZ11) 是一种有效的光敏剂,具有直接的抗肿瘤作用,以及对恶性病变的间接免疫依赖性破坏作用。
CAS No. :1224104-08-8
商品编号 规格 价格 会员价 是否有货 数量
PL10900-5mg 5mg ¥6107.00 请登录
PL10900-10mg 10mg ¥10447.00 请登录
PL10900-25mg 25mg ¥21698.00 请登录
PL10900-50mg 50mg 询价 询价
PL10900-100mg 100mg 询价 询价
PL10900-10mM*1mLinDMSO 10mM*1mLinDMSO ¥6718.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Redaporfin
英文名称
Redaporfin
英文别名
Redaporfin;ZP3QP1H44W;LUZ11 compound;Redaporfin [INN];Redaporfin [WHO-DD];J3.523.421G;Q27295827;5,10,15,20-tetrakis(2,6-difluoro-3-N-methylsulfamoylphenyl)bacteriochlorin
Cas No.
1224104-08-8
分子式
C48H38F8N8O8S4
分子量
1135.11
包装储存
Powder -20°C 3 years;4°C 2 years
详情描述
Redaporfin (LUZ11) 是一种有效的光敏剂,具有直接的抗肿瘤作用,以及对恶性病变的间接免疫依赖性破坏作用。
产品详情
Redaporfin (LUZ11) 是一种有效的光敏剂,具有直接的抗肿瘤作用,以及对恶性病变的间接免疫依赖性破坏作用。
生物活性
Redaporfin (LUZ11) acts as a potent photosensitizer. Redaporfin causes direct antineoplastic effects as well as indirect immune‐dependent destruction of malignant lesions.
性状
Solid
体外研究(In Vitro)
The combination photodynamic therapy (PDT) with Redaporfin (5μM) induces a reduction in the abundance of several Golgi apparatus (GA) proteins such as Golgi brefeldin A-resistant guanine nucleotide exchange factor 1 (GBF1), golgin subfamily A member 2 (GOLGA2), and galactosyltransferase 1 (GALT1), as well as that of two ER proteins, eukaryotic translation initiation factor 2-alpha (eIF2α) kinase 3 (EIF2AK3) and protein disulfide-isomerase A3 (PDIA3). In contrast, there is no major decrease in mitochondrial import receptor subunit TOM20 homolog (TOMM20) or in the cytoskeleton protein β-actin. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
ClinicalTrial
参考文献
[1]. Lígia C Gomes-da-Silva, et al. Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus. EMBO J. 2018 Jul 2;37(13):e98354.
溶解度数据
In Vitro: DMSO : 250 mg/mL (220.24 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2